Skip to main content

Table 3 Blood glucose level obtained during the OGTT before and after supplementation with AHE or placeboa

From: A randomized, double-blind, placebo-controlled crossover clinical trial to evaluate the anti-diabetic effects of Allium hookeri extract in the subjects with prediabetes

 

Test group (n = 22)

Placebo group (n = 22)

P-valueb

Week 0

Week 8

Change value

Week 0

Week 8

Change value

Blood glucose (mg/dL)

0 min

106.91 ± 7.21

107.55 ± 10.66

0.64 ± 8.51

108.55 ± 9.77

107.77 ± 10.43

−0.77 ± 7.56

0.569

30 min

182.36 ± 27.14

183.32 ± 20.41

0.95 ± 20.58

186.95 ± 28.25

187.64 ± 23.65

0.68 ± 27.52

0.968

60 min

216.86 ± 32.74

216.18 ± 46.24

−0.68 ± 32.57

197.77 ± 39.54

216.27 ± 46.07

18.50 ± 33.20

0.040

90 min

211.59 ± 50.02

209.27 ± 46.28

−2.32 ± 37.57

192.45 ± 44.93

214.45 ± 56.48

22.00 ± 55.40

0.149

120 min

196.77 ± 48.95

192.32 ± 44.99

−4.45 ± 39.49

182.82 ± 47.79

195.09 ± 51.71

12.27 ± 47.65

0.282

iAUC0–2 h (h*mg/dL)

167.51 ± 55.92

164.26 ± 57.42

−3.25 ± 38.59

144.37 ± 43.54

169.35 ± 63.80

24.98 ± 45.15

0.040

  1. OGTT oral glucose tolerance test; AHE Allium hookeri extract; iAUC incremental area under the curve
  2. aValues are presented as mean ± standard deviation
  3. bAnalyzed using t-test (difference between two groups in change from baseline)